ATS
MEDP icon

Ashton Thomas Securities’s Medpace MEDP Stock Holding History

Ashton Thomas Securities’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$249K Sell
471
-13
-3% -$6K 0.04% 273
2026
Q1 		$232K Buy
484
+14
+3% +$7.17K 0.03% 332
2025
Q4 		$264K Hold
470
– – 0.05% 227
2025
Q3 		$242K Buy
+470
New +$205K 0.03% 291
2024
Q4 		– Sell
-112
Closed -$37.4K – 847
2024
Q3 		$37.4K Buy
+112
New +$42.5K 0.01% 479

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Ashton Thomas Securities's MEDP Position: Q2 2026 in Review

Ashton Thomas Securities reduced its Medpace (MEDP) stake by 2.7% in Q2 2026, selling an estimated $6K and leaving 471 shares worth $249K. The position accounts for 0.04% of the portfolio, ranked #273.

Ashton Thomas Securities first reported a position in MEDP in Q3 2024 and has held it in 5 quarters since. The position peaked at $264K in Q4 2025. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Ashton Thomas Securities held 471 shares of Medpace worth $249K as of Q2 2026.
  • Ashton Thomas Securities sold 13 Medpace shares in Q2 2026, an estimated $6K.
  • Medpace made up 0.04% of Ashton Thomas Securities's portfolio in Q2 2026, its #273 holding.
  • Ashton Thomas Securities first reported a position in Medpace in Q3 2024 and has held it in 5 quarters since.
  • Ashton Thomas Securities's Medpace position peaked at $264K in Q4 2025.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Ashton Thomas Securities's 13F filing for Q2 2026, filed 27 Jul 2026.